Metyos Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
18
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
10
Metyos General Information
Description
Developer of bio-wearable technology designed to monitor chronic kidney disease. The company's platform utilizes a painless, arm-worn patch and miniaturized biosensor arrays to track biomarkers in real time, enabling patients and healthcare professionals to manage kidney function, adjust treatments, and anticipate adverse events through remote monitoring and cloud-integrated data analysis.
Contact Information
Website
www.metyos.comCorporate Office
- PC'Up - ESPCI
- 10 rue Vauquelin
- 75005 Paris
- France
Corporate Office
- PC'Up - ESPCI
- 10 rue Vauquelin
- 75005 Paris
- France
Metyos Timeline
Metyos Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Accelerator/Incubator | 18-Jun-2026 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue | |||
| 5. Seed Round | 26-Mar-2024 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 3. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue |
Metyos Comparisons
Industry
Financing
Details
Metyos Competitors (3)
One of Metyos’s 3 competitors is Kalium Health, a Venture Capital-Backed company based in Cambridge, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Kalium Health | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| Alio | Venture Capital-Backed | Broomfield, CO | ||||
| Biolinq | Venture Capital-Backed | San Diego, CA |
Metyos Patents
Metyos Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| FR-3167537-A1 | In vivo measurement system | Pending | 18-Oct-2024 | ||
| WO-2026082888-A1 | In vivo measurement system | Pending | 18-Oct-2024 | ||
| FR-3165725-A1 | Kit for detecting and/or measuring an analyte and/or a physiological parameter in a biological fluid | Pending | 23-Aug-2024 | ||
| WO-2026041768-A1 | Kit for detecting and/or measuring an analyte and/or a physiological parameter in a biological fluid | Pending | 23-Aug-2024 | ||
| FR-3132426-B1 | Analyte detection patch component and manufacturing method thereof | Active | 10-Feb-2022 | A61B5/685 |
Metyos Signals
Metyos Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| EIT Health | Accelerator/Incubator | |||
| MedTech Innovator | Accelerator/Incubator | |||
| Advans Lab | Accelerator/Incubator | Minority | ||
| Bpifrance | Sovereign Wealth Fund | Minority | ||
| Cenitz | Venture Capital | Minority |
Metyos FAQs
-
When was Metyos founded?
Metyos was founded in 2021.
-
Where is Metyos headquartered?
Metyos is headquartered in Paris, France.
-
What is the size of Metyos?
Metyos has 18 total employees.
-
What industry is Metyos in?
Metyos’s primary industry is Monitoring Equipment.
-
Is Metyos a private or public company?
Metyos is a Private company.
-
What is Metyos’s current revenue?
The current revenue for Metyos is .
-
How much funding has Metyos raised over time?
Metyos has raised $2.5M.
-
Who are Metyos’s investors?
EIT Health, MedTech Innovator, Advans Lab, Bpifrance, and Cenitz are 5 of 10 investors who have invested in Metyos.
-
Who are Metyos’s competitors?
Kalium Health, Alio, and Biolinq are competitors of Metyos.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process